Dreve-otoplastik Gmbh

Reiner Altman

Martin Klare

Thomas Veit

Michael Kutschinski

The invention relates to a biocompatible, low-viscosity, radiation-curable formulation for producing medical products, in particular adaptive ear pieces, otoplastic parts, shells or ear parts, by means of PNP methods or stereolithographic methods. Said formulation comprises: a) 15-60 wt. % of a monomeric or oligomeric dimethacrylate based on bisphenol A or bisphenol F; b) 0-50 wt. % one or more monomeric or oligomeric urethane (meth)acrylates with a functionality n&#x3c;4, a viscosity &#x3c;30 Pa s and a molecular weight &#x3c;3500; c) 2-25 wt. % of a monomeric, aliphatic or cycloaliphatic dimethacrylate with a viscosity &#x3c;3 Pa s; d) 2-35 wt. % of an iminooxadiazone dion derivative, characterised by 3 methacrylate and/or acrylate functions; 0-15 wt. % one or more monofunctional methacrylates; f) 0.5-6 wt. % of a photo initiator or a combination of photo initiators, whose absorption lies in the wavelength range of the laser beam that is used or the irradiation source; g) 0-0.5 wt. % one or more anaerobic inhibitors; h) 0-40 wt. % fillers with a particle size &#x3c;25 &#x3bc;m; i) 0-5 wt. % colorants; j) 0-5 wt. % conventional additives such as UV stabilisers or process additives, whereby the sum of the fraction of the components a) to j) totals 100 wt. %.

Growing community of inventors

Castrop-Rauxel, Germany

Reiner Altman